Brain Ischemia Market 2018 Progress | Size, Potential, Growth and Trend | A Definite Shift towards the Developing World | Forecasts till 2023

“Brain Ischemia Market”
The Analysis presents the study of Global Brain Ischemia Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold. published a Half-Cooked research report on “Global Brain Ischemia Market Research Report – Forecast to 2023” reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.


The global brain ischemia market is expected to grow at a CAGR of 6.5% during forecasted period 2017-2023.

The report titled “Brain Ischemia Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Brain Ischemia Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market!

Market Highlights:

Brain ischemia is a medical condition in which there is lack of oxygen supply to the brain. This is due to narrowing of blood vesicles which is caused due to blood clot or other factors like cholesterol. Since   last few years’ global brain ischemia market has been growing swiftly and is expected to grow at CAGR of 6.5 % from 2017 to2023. Due to increasing prevalence of cardiovascular diseases and other diseases which are affecting cardiovascular which is major factor that causes brain ischemia. Beside this adoption of sedentary lifestyle by the people across the globe has provided fuel for the growth of this market.

Geographically, global ischemia market is segmented into four major regions, North America, Europe, Asia Pacific plus Middle East and Africa. The worth of this market in 2016 was 1.43 billion and is expected to reach till 2023 billion by the end of 2023 by growing continuously at the CAGR of 6.5 %. North America contribute the highest share in the brain ischemic market. Due to increasing number of diabetic, obese and aging population in North America are major driving factor for the growth of this. Among all regions, ischemia’s market in Asia Pacific is the fastest growing market.  . Due to a huge population and increasing prevalence of diseases like sickle cell anemia and diabetes in this region all these together has served to a  platform for the growth of the market here.

Competitive Analysis:

Key player  in  the global brain ischemia market are Bayer AG (Germany), H. Lundbeck A/S (Denmark), Bristol-Myers Squibb Company (US), Boehringer Ingelheim GmbH (Germany), ThromboGenics NV (Belgium), Vernalis Plc (UK), Neurotec Pharma SL (Spain), Johnson and Johnson (US), Covidien Plc (Ireland), Stryker Corporation (US), Abbott Laboratories (US), Penumbra, Inc. (US), Philips Healthcare (Netherland), Hitachi Ltd. (Japan), GE Healthcare (UK) and  Siemens Healthcare (US).

Due to increasing prevalence of many disease which causes brain ischemia; all these have attracted many multinational companies to develop their market in the global brain ischemia market.  Companies are using the trend of strategic alliance and acquisition to gain a high position and minimize competition in the market

Bristol-Myers Squibb International which is headquartered in US; it’s working on the trials of CV006-004, Acute Viprinex™ which are used for the treatment of brain ischemia.

A/S has presented a new effective and safe data for desmoteplase which is a thrombolytic drug used for the treatment of acute ischemic stroke. It has received fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of acute ischemic stroke.

Stryker Corporation’s new drug “Trevo® Retriever” has shown a remarkable results when used in the treatment of brain ischemia. This drug is the declared as a front-line treatment to reduce disability in ischemic stroke since last 20 years.

Penumbra, Inc. which is a medical device manufacturing company has launched the new MAX™ system reperfusion catheters for the treatment of acute ischemic stroke patients.

Boehringer Ingelheim GmbH a German headquartered company that has introduce Pradaxa® (dabigatran etexilate) an anticoagulant drug for the treatment of brain ischemia.

Market Assessment:

The report of global brain ischemia market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the market’s segments and regions.

 Intended Audience:

  • Research and development (R&D) companies
  • Pharmaceutical companies
  • Government and independent research laboratories
  • Contract research organizations (CROs)
  • Medical research laboratories
  • Academic medical institutes and universities


Global brain ischemia market is segmented on the basis of diagnosis which includes   MRI, CT, ultrasound, angiography and other. The market is also segmented on the basis of treatment which includes angioplasty, drug treatment and other. Drug treatment is sub segmented into anticoagulation therapy, antiplatelet and other. Anticoagulation therapy is further sub segmented into heparin and warfarin. Antiplatelet therapy is further sub segmented as aspirin and other. On the basis of end user the market is segmented as hospital, clinics and other.

Regional Analysis:

On regional basis, North America has the largest market of brain ischemia.  Due to the increasing diabetic and obese population in this region, these have become a major driving factor for this market’s growth. Moreover increasing government’s support has also lead to the growth of this market. Europe is the second largest market due to increasing aging population and technological advances here. Emerging economies like India and China in Asia-Pacific region has provided to be a fuel for the growth of this market here.  Middle East and Africa contributes less to this market’s growth.



About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India